Why We May Never Know Whether the $56,000-a-Year Alzheimer’s Drug Actually Works
It could take years for follow-up studies to prove Aduhelm slows the disease — or doesn’t. Meanwhile, its maker will profit.
http://dlvr.it/S3YCkD
http://dlvr.it/S3YCkD
Comments
Post a Comment